News

In parallel, e-therapeutics has successfully completed GMP manufacturing of the clinical batch of ETX-312, supporting the Company’s operational readiness to progress to first-in-human dosing.
ETX-312 well tolerated at exaggerated dose levels in GLP-compliant toxicology studies GMP manufacturing of clinical trial batch successfully completed On track for CTA submission in Q4 2025 LONDON ...
Onco-Innovations inks agreement with Nucro-Technics for IND-enabling studies: Vancouver, Canada Tuesday, July 8, 2025, 10:00 Hrs [IST] Onco-Innovations Limited, a Canadian-based c ...
Noida: Jubilant Biosys Limited, a subsidiary of Jubilant Pharmova, has announced the appointment of Venugopala Reddy Pagadala ...
Our client is a professional management consultancy and IT services provider, focused on delivering creative and innovative digital solutions. Their client base includes both startups and large ...
Our client is a professional management consultancy and IT services provider, focused on delivering creative and innovative digital solutions. Their client base includes both startups and large ...
Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.
Get the latest Global Partners LP (GLP) stock news and headlines to help you in your trading and investing decisions.
As investors await the opening of Anthem Biosciences IPO, here are the key strengths and risks outlined in its Red Herring ...
White Force is set to finalise IPO share allotment by the end of July 8, and its equity shares will be available for trading ...
A new study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight. The observational study of more than 170,000 ...